CFS
NVCR icon

CGC Financial Services’s NovoCure NVCR Stock Holding History

CGC Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed -$535 – 341
2025
Q1 		$535 Hold
30
– – ﹤0.01% 307
2024
Q4 		$894 Hold
30
– – ﹤0.01% 305
2024
Q3 		$469 Hold
30
– – ﹤0.01% 315
2024
Q2 		$514 Hold
30
– – ﹤0.01% 313
2024
Q1 		$469 Hold
30
– – ﹤0.01% 325
2023
Q4 		$448 Hold
30
– – ﹤0.01% 336
2023
Q3 		$485 Hold
30
– – ﹤0.01% 293
2023
Q2 		$1.25K Buy
+30
New +$1.86K ﹤0.01% 282

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CGC Financial Services's NVCR Position: Q2 2025 in Review

CGC Financial Services sold out of NovoCure (NVCR) in Q2 2025, closing a stake of 30 shares — an estimated $535 sold.

CGC Financial Services first reported a position in NVCR in Q2 2023 and held it in 8 quarters. The position peaked at $1.25K in Q2 2023. 242 funds tracked by Wall St. Rank hold NVCR as of Q2 2025.

  • CGC Financial Services reported no remaining NovoCure position as of Q2 2025 after selling out during the quarter.
  • CGC Financial Services sold 30 NovoCure shares in Q2 2025, an estimated $535.
  • CGC Financial Services first reported a position in NovoCure in Q2 2023 and held it in 8 quarters.
  • CGC Financial Services's NovoCure position peaked at $1.25K in Q2 2023.
  • 242 funds tracked by Wall St. Rank held NovoCure as of Q2 2025.

Based on CGC Financial Services's 13F filing for Q2 2025, filed 28 Jul 2025.